Table 3.
Study group (intervention orcontrol group) in relationto the concordance betweeninfluential side effects and6-month treatment choice
|
6-month treatment choice |
Casesa/ Totalb |
Unadjusted |
Adjustedc |
||
|---|---|---|---|---|---|
| OR | 95%CI | OR | 95%CI | ||
| All treatments |
211 / 448 |
0.82 |
(0.56, 1.2) |
0.76 |
(0.51, 1.2) |
| Active surveillance |
39 / 68 |
0.38 |
(0.14, 1.0) |
0.16 |
(0.03, 0.79) |
| External beam radiotherapy |
28 / 94 |
1.2 |
(0.51, 3.0) |
1.3 |
(0.49, 3.7) |
| Brachytherapy |
23 / 63 |
0.98 |
(0.32, 3.0) |
0.96 |
(0.11, 8.3) |
| Prostatectomy | 121 / 223 | 0.90 | (0.53, 1.5) | 0.87 | (0.49, 1.6) |
a. Number of concordant cases.
b. Total number treated.
c. Adjusted for health care site, age at enrollment, full-time work status, health insurance type, internet as an information source for prostate cancer, trait anxiety, age as a factor in treatment choice, influence of recreational or work activities as considering treatment choice, importance or influence of confidence or lack of confidence in a particular doctor in treatment choice, and importance or influence of survival on treatment choice.